ONCOLYTICS BIOTECH INC
ONCY
ONCY was delisted on the 4th of November, 2015.
33 hedge funds and large institutions have $1.44M invested in ONCOLYTICS BIOTECH INC in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
14% more call options, than puts
Call options by funds: $8K | Put options by funds: $7K
10% more funds holding
Funds holding: 30 → 33 (+3)
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
40% less capital invested
Capital invested by funds: $2.38M → $1.44M (-$946K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$77.5K |
| 2 |
Morgan Stanley
New York
|
+$49.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$15K |
| 4 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
+$8.99K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$2.42K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$875K |
| 2 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$90.9K |
| 3 |
Jane Street
New York
|
-$36K |
| 4 |
Goldman Sachs
New York
|
-$15.4K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$14.8K |
ONCY Hedge Fund Activity: Q4 2014 in Review
33 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q4 2014, worth a combined $1.44M — down 40% from $2.38M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ONCY positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 9 trimmed.
The largest buyer was Virtu KCG Holdings, adding an estimated $77.5K. The largest seller was 1832 Asset Management, cutting an estimated $875K.
- 33 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q4 2014, up from 30 in Q3 2014.
- Funds reported $1.44M of ONCOLYTICS BIOTECH INC stock for Q4 2014, down 40% quarter-over-quarter.
- 7 funds opened new ONCOLYTICS BIOTECH INC positions in Q4 2014 and 3 closed out, a net change of +4 holders.
- The largest ONCOLYTICS BIOTECH INC buyer in Q4 2014 was Virtu KCG Holdings, an estimated $77.5K added.
- The largest ONCOLYTICS BIOTECH INC seller in Q4 2014 was 1832 Asset Management, an estimated $875K sold.
Based on aggregated 13F filings for Q4 2014.